Neogen Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026 - Outcome of Board Meeting.
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Neogen Chemicals reported standalone revenue from operations of Rs 855.49 crore for FY2026, up 10.6% from Rs 773.65 crore in FY2025. Profit after tax declined slightly to Rs 46.96 crore from Rs 48.41 crore (down ~3%). Operating margin expanded significantly to 17.68% from 10.33% in the prior year. The auditors issued an unmodified (clean) opinion but included an Emphasis of Matter regarding the Dahej SEZ fire incident in March 2025, with Rs 188.96 crore insurance claim still outstanding. Operating cash flow turned negative at Rs 99.20 crore vs positive Rs 198.76 crore in FY2025, primarily due to working capital buildup. The Board also recommended a dividend of Re 1 per share and approved a preferential equity issue of 10 lakh shares to promoter group entity Cadamba Solutions.
Revenue grew modestly but PAT was flat to slightly lower. The significant negative operating cash flow and large outstanding insurance claim are concerns despite margin expansion. The clean audit opinion is positive for investors.